Abstract
Sparfloxacin, a new quinolone antibacterial was used to treat one hundred and thirty two patients with acute purulent sinusitis, at a dosage of 400 mg on the first day followed by 200 mg once daily for a further four days. A clinically successful outcome (defined as disappearance of nasal discharge, fever, pain, tenderness over the sinuses and headache) was recorded in 122 ( 95.3%) patients. Sparfloxacin was well tolerated. Fourteen adverse experiences were reported in 7 patients ( 5.3%); they were mainly gastrointestinal and mild. No phototoxic or cardiological adverse events occurred. An unusual feature was that Staphylococcus aureus and Pseudomonas spp. were the most common bacterial species isolated from middle meatal was of patients in this study.
References
Ylikoski J, Sarolainen S and Jousimies — Somen H (1989): The bacteriology of acute maxillary sinusitis. Journal of Otorhinolaryngology and its related specialities 51: 175–181.
Baquero F and Canton R (1996): In-vitro activity of sparfloxacin in comparison with currently available antimicrobials against respiratory tract pathogens. Journal Antimicrobial Chemotherapy 37 (Supp A): 1–18.
Montay G (1996): Pharmacokinetics of sparfloxacin in healthy volunteer and patients: a review. Journal of Antimicrobial Chemotherapy 37 (Suppa A) : 27–29.
Wise R and Honeybourne D (1996): A review of the penetration of sparfloxacin into the lower respiratory tract and sinuses. Journal of Antimicrobial Chemotherapy, 37 (Supp A) : 57–63.
Gehanno P, Berche P and the Sinusitis Study Group (1996): Sparfloxacin versus cefuroxime-axetil in the treatment of acute purulent sinusitis. Journalof Antimicrobial Chemotherapy 37 (Supp A ): 105–114.
Kojima T and Mitsuhashiv S (1991): In-vitro and in-vivo antibacterial activity of sparfloxacin. Chemotherapy 39 (Suppl.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Juvekar, R.V., Mishra, S.C., Naik, S. et al. Sparfloxacin in the treatment of purulent sinusitis—a multicentric study in Indian patients. IJO & HNS 51, 80–83 (1999). https://doi.org/10.1007/BF02996857
Issue Date:
DOI: https://doi.org/10.1007/BF02996857